MHUA
NASDAQMeihua International Medical Technologies Co. Ltd.
Website
News25/Ratings0
News · 26 weeks40%
2025-10-262026-04-19
Mix090d
No activity.
Latest news
25 items- SECSEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- PRMeihua International Medical Technologies Co., Ltd. Received Nasdaq Delisting NoticeYangzhou, China, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Meihua International Medical Technologies Co., Ltd. ("Meihua" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, announced today that the Company received a letter from the Nasdaq Stock Market LLC ("Nasdaq") on December 2, 2025, notifying the Company that the Nasdaq staff has determined to delist the Company's ordinary shares from The Nasdaq Capital Market (the "Delisting Determination"), because the Company failed to regain compliance with the Nasdaq Listing Rule 5550(a)(2) (the "Rule"). As previously disclosed, on December 3, 2
- PRMeihua International Announces 1-For-100 Reverse Share SplitYANGZHOU, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Meihua International Medical Technologies Co., Ltd. ("Meihua" or the "Company") (NASDAQ:MHUA), reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that it would effectuate a reverse share split of its outstanding ordinary shares, par value of $0.0005 per share, at a ratio of 1-for-100, and implement its dual-class share structure, to be effective at the open of business on Monday, November 24, 2025. Following the reverse share split, the Company's class A ordinary shares will have a new par value of $0.05 per share and will continue to trade on Nasdaq unde
- SECSEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- SECSEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- SECSEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- SECSEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- SECSEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- SECSEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- SECSEC Form 424B3 filed by Meihua International Medical Technologies Co. Ltd.424B3 - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- SECSEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- SECSEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- SECSEC Form 20-F filed by Meihua International Medical Technologies Co. Ltd.20-F - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- PRMeihua International Medical Technologies Co., Ltd. Reports 2024 Financial Year ResultsYANGZHOU, China, April 25, 2025 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced its financial results for the fiscal year ended December 31, 2024. All amounts below are in U.S. dollars. Fiscal Year 2024 Financial Metrics: Revenues remained stable and decreased slightly to $96.91 million for the year ended December 31, 2024, from approximately $97.10 million for the year ended December 31, 2023. The decrease was mainly due to the Company's disposal of Hainan Guoxie Technology Group Co. Ltd (
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Meihua International Medical Technologies Co. Ltd.SCHEDULE 13G/A - Meihua International Medical Technologies Co., Ltd. (0001835615) (Subject)
- SECSEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- SECSEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- SECSEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- 13D/GSEC Form SC 13G filed by Meihua International Medical Technologies Co. Ltd.SC 13G - Meihua International Medical Technologies Co., Ltd. (0001835615) (Subject)
- SECSEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- SECSEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- PRMeihua International Medical Technologies Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price RequirementYANGZHOU, China, Oct. 7, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that on October 3, 2024, it received a notification letter (the "Notification Letter") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Requirement"). As previously reported, the Company was notified on April 2, 2024, t
- PRMeihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial ResultsYANGZHOU, China, Sept. 20, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today reported its unaudited financial results for the six months ended June 30, 2024. All amounts below are in U.S. dollars. First Half 2024 Unaudited Financial Metrics: Revenues was approximately $45.3 million for the six months ended June 30, 2024.Gross profit was approximately $15.2 million for the six months ended June 30, 2024.Gross margin was approximately 33.5% in the six months ended June 30, 2024.Income from operation
- SECSEC Form 6-K filed by Meihua International Medical Technologies Co. Ltd.6-K - Meihua International Medical Technologies Co., Ltd. (0001835615) (Filer)
- PRMeihua International Medical Technologies Co., Ltd. to Present at LIVE! with Webull Corporate Connect: Virtual Healthcare Investment Webinar on August 28, 2024YANGZHOU, China, Aug. 26, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that Xin "Steven" Wang, Chief Executive Officer of Meihua, will present and discuss recent corporate events at LIVE! with Webull Corporate Connect: Virtual Healthcare Investment Webinar on Wednesday, August 28, 2024, at 3:00 PM ET. Conference Details: Conference: LIVE! with Webull Corporate Connect: Virtual Healthcare Investment Webinar Date/Time: Wednesday, August 28, 2024, at 3:00 PM ET Presenter: Xin "Steven"